Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates

Transfusion and Apheresis Science

Volumn 45, Issue 1, 2011, Pages 75-84

  Seghatchian, Jerard ^a   Hervig, Tor ^b,c   Putter, Jeffrey S ^d  

^a Blood Components Technology Consultancy   (United Kingdom)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d Medical Biomechanics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; RIBOFLAVIN; THROMBOCYTE CONCENTRATE;

ARTICLE; ASEPSIS; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLOOD COMPONENT; BLOOD FILTER; BLOOD STORAGE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE PRESERVATION; HUMAN; INFECTION PREVENTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGEN CLEARANCE; PATHOGEN INACTIVATION TECHNOLOGY; PROCESS TECHNOLOGY; QUALITY CONTROL; SAFETY; THROMBOCYTE PRESERVATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION;

BACTERIAL INFECTIONS; BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD-BORNE PATHOGENS; ERYTHROCYTES; HUMANS;

EID: 84860389134     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.06.006     Document Type: Article

References (36)

1. Stowell C.P. Theme section: effect of storage on the biology and clinical efficacy of banked RBC. Transfus Apher Sci 2010, 43:45-107.
2. Hess J.R. Red cell changes during storage. Transfus Apher Sci 2010, 43:51-59.
3. Seghatchian J., Krailadsiri P. Red cell storage lesion assessed by levels of K, Hb, and Annexin V in supernatants. Transfus Apher Sci 2002, 26:130-142.
4. Bessos H., Seghatchian J. Red cell storage lesion: the potential impact of storage-induced CD47 decline and Immunomodulation and the survival of leucofiltered red cells. Transfus Apher Sci 2005, 30:227-232.
5. Krailadsiri P., Seghatchian J., Mac Grego I., et al. The effects of leucodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006, 43:407-417.
6. Seghatchian J. Platelet storage lesion: an update on the impact of various leuco-reduction processes on the biological response modifiers. Transfus Apher Sci 2006, 34:125-130.
7. Seghatchian J. Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned. Transfus Apher Sci 2003, 29:105-117.
8. Seghatchian J., de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006, 35:189-196.
9. Solheim B., Seghatchian J. Pathogen inactivation. Rossi's principles of transfusion medicine 2009, 801-810. Blackwell Publishing Ltd, Philadelphia. T.L. Simon, E.L. Snyder, B. Solheim, C.P. Stowell, R.G. Strauss, M. Petridis (Eds.).
10. Cancelas J.A. Pathogen inactivation of red cell components. Pathogen inactivation: the penultimate paradigm shift 2010, 49-67. AABB Press, Bethesda, MA. J.P. AuBuchon, C. Prowse (Eds.).
11. AuBuchon J.P. Current status of pathogen inactivation methods. ISBT Sci Ser 2010, 125-133.
12. McCullough J. Pathogen inactivation of platelets. Pathogen inactivation: the penultimate paradigm shift 2010, 99-123. AABB Press, Bethesda, MA. J.P. AuBuchon, C. Prowse (Eds.).
13. Osselaer C., Doyen C., Defoin L., et al. Universal adoption of pathogen inactivation of platelet components: impact of platelet and red blood cell component use. Transfusion 2009, 49(1):412-422.
14. Mohr H., Gravemann U., Bayer A., Muller T.H. Sterilisation of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009, 49:1956-1963.
15. McClaskey J., Xu M., Snyder E.L., Tormey C.A. Clinical trials for pathogen reduction in transfusion medicine: a review. Transfus Apher Sci 2009, 41:217-225.
16. Stramer S.L., Hollinger F.B., Katz L.M., et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009, 49(Suppl 2):1S-29S.
17. Seghatchian J., Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997, 11:130-144.
18. Krailadsiri P., Seghatchian J., Amiral J., et al. Annexin V, a new marker of platelet storage lesion: correlation with dMPV. Transfus Apher Sci 1997, 18:223-226.
19. Seghatchian J. A new method for the assessment of pro/anti-coagulant property of platelet-derived microvesicles and its usefulness for quality monitoring of platelet haemostatic function. Transfus Apher Sci 2003, 29:119-121.
20. Wadhawa M., Seghatchian J., Thorpe R. Are cytokines in platelet concentrates responsible for febrile transfusion reactions. Transfus Apher Sci 1997, 18:367-371.
21. Seghatchian J, Tolksdorf F, Struff W. Characteristics of the Theraflex UV platelets pathogen inactivation system. Transfus Apher Sci, submitted for publication.
22. Seltsman A, Muller TH. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother, in press;1.
23. Klein H.G., Anderson D., Bernandli M.J., et al. Pathogen inactivation: making decisions about new technologies: report of a consensus conference. Transfusion 2007, 47:2338-2347.
24. Murphy W.F., Foley M., Doherty C., et al. Screening platelet concentrates for bacteria concentration: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008, 95:13-19.
25. Hervig T., Seghatchian J., Apelseth T.O. Current debate on pathogen inactivation of platelet concentrates - to use or not to use?. Transfus Apher Sci 2010, 43:411-414.
26. Seifried E., Henschler R., Mueller M.M. European perspectives on implementation. Pathogen inactivation: the penultimate paradigm shift 2010, 261-278. AABB Press, Bethesda, MA. J.P. AuBuchon, C. Prowse (Eds.).
27. Dzik W. Fresh blood for everyone? Balancing availability and quality of stored RBCs. Short communication. Transfus Med 2008, 18:260-265.
28. Koch C.G., Li L., Sessler D.I. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
29. Purdy F.R., Tweeddale M.G., Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997, 44:1256-1261.
30. Zallen G., Offner P.J., Moore E.E. Age of transfused blood is independent risk factor for postinjury multiple organ failure. Am J Surg 1999, 178:570-572.
31. Vamvakas E.C., Carven J.H. Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000, 40:101-109.
32. Leal-Noval S.R., Jara-Ló pez I., Garci{dotless}́a-Garmendia J.L. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003, 98:815-822.
33. Mynster T., Nielsen H.J. Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 2001, 44:955-964.
34. Offner P.J., Moore E.E., Biffl W.L., Johnson J.L., Silliman C.C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002, 137:711-716.
35. Basran S., Frumento R.J., Cohen A. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 2006, 103:15-20.
36. van deWatering L., Lorinser J., Versteegh M., Westendord R., Brand A. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006, 46:1712-1718.